Embla Medical hf (OCSE:EMBLA) Change In Receivables : kr-118 Mil (TTM As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf Change In Receivables?

Embla Medical hf's change in receivables for the quarter that ended in Mar. 2024 was kr-33 Mil. It means Embla Medical hf's Accounts Receivable increased by kr33 Mil from Dec. 2023 to Mar. 2024 .

Embla Medical hf's change in receivables for the fiscal year that ended in Dec. 2023 was kr-112 Mil. It means Embla Medical hf's Accounts Receivable increased by kr112 Mil from Dec. 2022 to Dec. 2023 .

Embla Medical hf's Accounts Receivable for the quarter that ended in Mar. 2024 was kr894 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Embla Medical hf's Days Sales Outstanding for the three months ended in Mar. 2024 was 59.50.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Embla Medical hf's liquidation value for the three months ended in Mar. 2024 was kr-3,875 Mil.

Embla Medical hf Change In Receivables Historical Data

The historical data trend for Embla Medical hf's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Change In Receivables Chart

Embla Medical hf Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-75.47

112.80

-86.76

-92.68

-111.89

Embla Medical hf Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-27.63	-62.78	-16.23	-6.40	-33.07

Embla Medical hf Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-118 Mil.

Embla Medical hf (OCSE:EMBLA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Embla Medical hf's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	893.983	/	1370.945	*	91
=	59.50

2. In Ben Graham's calculation of liquidation value, Embla Medical hf's accounts receivable are only considered to be worth 75% of book value:

Embla Medical hf's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	530.66	-	5561.631	+	0.75 * 893.983	+	0.5 * 971.835
=	-3,875

Embla Medical hf Change In Receivables Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Embla Medical hf (OCSE:EMBLA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

OSSFF:USA OSSUY:USA

Address

Grjothals 5, Reykjavik, ISL

Website

https://www.ossur.com

Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Embla Medical hf (OCSE:EMBLA) Headlines

No Headlines